Researchers at the University of Manchester in the UK recently published a paper in the “British Journal of Cancer” saying that using biomaterials to construct three-dimensional tumor models close to the actual human tumor environment in the laboratory will help speed up the development of anti-cancer drugs. According to a press release issued by the University of Manchester, researchers analyzed cancer tumor models based on advanced biomaterials such as hydrogels. This type of material can act as a scaffold for cells to adhere to and grow. Various cells can be added to the three-dimensional structure formed by it, and a miniature “tumor ecosystem” can be constructed to simulate and analyze characteristics such as cell-to-cell interactions and drug resistance.

Researchers at the University of Manchester in the UK recently published a paper in the “British Journal of Cancer” saying that using biomaterials to construct three-dimensional tumor models close to the actual human tumor environment in the laboratory will help speed up the development of anti-cancer drugs. According to a press release issued by the University of Manchester, researchers analyzed cancer tumor models based on advanced biomaterials such as hydrogels. This type of material can act as a scaffold for cells to adhere to and grow. Various cells can be added to the three-dimensional structure formed by it, and a miniature “tumor ecosystem” can be constructed to simulate and analyze characteristics such as cell-to-cell interactions and drug resistance.